Connect with:
Tuesday / October 22. 2024
HomeAgrotechE-commerceBASF launches soybean seed with Enlist E3 Technology

BASF launches soybean seed with Enlist E3 Technology

corteva-agriscience-launches-brand-in-myanmar
source-public domain(comodityonline.com)

Enlist E3 soybeans provide tolerance to Liberty herbicide, new 2,4-D choline and glyphosate

 

BASF announces the U.S. launch of Xitavo Brand soybean seed with Enlist E3 technology. Xitavo Brand soybean seed is owned by MS Technologies and exclusively distributed by BASF.

With weed resistance increasing, growers need new tools to improve soybean efficiency and productivity. Xitavo soybean seed delivers an innovative solution to growers seeking a new soybean seed option.

“At MS Technologies, we’re committed to providing leading solutions and better choices for soybean growers,” says Joe Merschman, president of MS Technologies. “We know that higher yields are always top of mind for growers, and we’re excited to collaborate with BASF to bring this new technology to market to help growers get the most out of every acre.”

Xitavo soybean seed includes the Enlist E3 triple-stack herbicide tolerant trait. Enlist E3 soybeans provide tolerance to Liberty herbicide, new 2,4-D choline and glyphosate. With the ability to use these three herbicides, soybean growers can employ multiple modes of action against their most troublesome weeds. Xitavo will be available in 19 varieties covering relative maturities group 0.1-4.6. With this new seed, soybean growers have more choice and flexibility in selecting herbicide tolerance traits, genetics, BASF seed treatments and crop protection solutions.

“Success for growers starts with good seed,” says Doug Little, BASF Soybean Seed Marketing Manager. “BASF is expanding its soybean seed portfolio to offer growers the options they need and the flexibility they want.”

BASF’s broad portfolio of seed treatment and crop protection products can protect and nurture these soybean varieties to help maximize their full potential.

 

 
 
 
 

 

 

 

 

Share

No comments

leave a comment